NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP

NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP

Background NeiyiKangfu tablets (NYKF) are widely used clinically for the treatment of endometriosis (EMS), whose mechanism of action has been extensively studied. Researchers have found that NYKF may control the development of ectopic lesions by inhibiting angiogenesis and inflammatory cytokine secr...

Full description

Bibliographic Details
Main Authors: Yi Wen, Lingxiu Fan, Lili Pang, Tingting Zhao, Ruonan Li, Ying Zhang, Liye Zhang, Wei Yang
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Gynecological Endocrinology
Subjects:
NeiyiKangfu tablets
endometriosis
RAF/MEK/ERK signaling pathway
RKIP
apoptosis
内异康复片
Online Access:https://www.tandfonline.com/doi/10.1080/09513590.2022.2162495

Internet

https://www.tandfonline.com/doi/10.1080/09513590.2022.2162495

Similar Items